SCHEMBL21821811

SCHEMBL21821811

O=C1CC(c2ccccc2)NC(=O)/C1=C\NCCN1CCN(CCO)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC18A3 Q16572 1/20 0.40
▸ KDM1A O60341 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP2C19 P33261 1/20 0.35
▸ HTT P42858 1/20 0.34
▸ LDHA P00338 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ CDK4 P11802 1/20 0.34
▸ CCND1 P24385 1/20 0.34
▸ SIGMAR1 Q99720 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ PRKCG P05129 1/20 0.33
▸ PRKCB P05771 1/20 0.33
▸ PRKCA P17252 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ MAP1LC3B Q9GZQ8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21821813 1.00 SLC18A3 (0.40) SLC18A3KDM1AALDH1A1CYP2C19HTT
SCHEMBL24379786 0.85 SLC18A3 (0.38) SLC18A3KDM1AALDH1A1CYP2C19HTT
SCHEMBL22111757 0.83 TSHR (0.36) ALDH1A1CYP2C19MAPK1MAPTSIGMAR1
SCHEMBL21821591 0.83 SLC18A3 (0.50) SLC18A3KDM1AALDH1A1CYP2C19MEN1
SCHEMBL21821620 0.80 SLC18A3 (0.40) SLC18A3KDM1AALDH1A1CYP2C19HTT
SCHEMBL21821618 0.80 SLC18A3 (0.40) SLC18A3KDM1AALDH1A1CYP2C19HTT
SCHEMBL26524902 0.80 SLC18A3 (0.40) SLC18A3KDM1AALDH1A1CYP2C19HTT
SCHEMBL21821651 0.79 KDM1A (0.41) SLC18A3KDM1AALDH1A1CYP2C19HTT
SCHEMBL21821648 0.79 KDM1A (0.41) SLC18A3KDM1AALDH1A1CYP2C19HTT
SCHEMBL21821816 0.78 KDM1A (0.40) SLC18A3KDM1AALDH1A1CYP2C19HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3632903-B1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF WIGEN BIOMEDICINE TECH SHANGHAI CO LTD (CN) 2023-10-11 — — EP disclosed
EP-3632903-B1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF WIGEN BIOMEDICINE TECH SHANGHAI CO LTD (CN) 2023-10-11 — — EP disclosed
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2022-05-03 — — US disclosed
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2020-06-18 — — US disclosed
EP-3632903-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF Wigen Biomedicine Technology (Shanghai) Co., Ltd. (CN) 2020-04-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof ATG7, SQSTM1, BECN1 SLC18A3 2277/4885KDM1A 3424/4885ALDH1A1 4264/4885
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF ATG7, SQSTM1, BECN1 SLC18A3 2277/4885KDM1A 3424/4885ALDH1A1 4264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback